1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Cholera Vaccines Market
2.2. Global Cholera Vaccines Market, By Product, 2023 (US$ Million)
2.3. Global Cholera Vaccines Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Cholera Vaccines Market: Competitive Analysis
3.1. Market Positioning of Key Cholera Vaccines Market Vendors
3.2. Strategies Adopted by Cholera Vaccines Market Vendors
3.3. Key Industry Strategies
4. Cholera Vaccines Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Cholera Vaccines Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Dukoral
5.3.2. Shanchol
5.3.3. Vaxchora
5.3.4. Others


6. North America Cholera Vaccines Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
6.3.Cholera Vaccines Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)

7. UK and European Union Cholera Vaccines Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
7.3.Cholera Vaccines Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)

8. Asia Pacific Cholera Vaccines Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
8.3.Cholera Vaccines Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)

9. Latin America Cholera Vaccines Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
9.3.Cholera Vaccines Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)

10. Middle East and Africa Cholera Vaccines Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
10.3.Cholera Vaccines Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Cholera Vaccines Market: By Product, 2022-2032, USD (Million)

11. Company Profile
11.1. Astellas Pharma, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Sonofi
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Emergent BioSolutions, Inc. (PaxVax, Inc.)
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Valneva SE
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Eubiologics Co. Ltd.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. GlaxoSmithKline plc (GSK)
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Merck & Co., Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Celldex Therapeutics, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Mitsubishi Tanabe Pharma Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Takeda Pharmaceutical Co. Ltd
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Johnson & Johnson (Crucell)
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives